Introduction
============

Organophosphorus nerve agents are considered to be the most dangerous chemical warfare agents. These compounds pose potential neurotoxic threats to both military and civilian populations as evidenced by terrorist attacks in Japan ([@b26]). Their acute toxic effects are based on the phosphonylation of acetylcholinesterase (AChE, EC 3.1.1.7), leading to the irreversible inhibition of its active site and subsequent overstimulation of postsynaptic cholinergic receptors due to the accumulation of the neurotransmitter acetylcholine in synapses of the central and peripheral nervous systems ([@b21]; [@b20]).

The medical countermeasures of nerve agent poisonings include the administration of the antidotes that are able to counteract the main toxic effects of nerve agents. The standard antidotal treatment of nerve agent poisoning usually includes an anticholinergic agent to block the overstimulation of cholinergic receptors and an oxime to reactivate nerve agent-inhibited AChE ([@b4]; [@b30]). The compounds with nucleophilic oximate anion were discovered and considered to be able to reactivate nerve agent-inhibited AChE by dephosphonylating the enzyme active site and restoring its activity. However, some nerve agents were found to be resistant to standard antidotal treatment. One of the most resistant nerve agents is tabun (O-ethyl-N,N-dimethyl phosphoramidocyanidate). Deleterious effects of tabun are extraordinarily difficult to antagonize because of the changes in hydrogen bonding and the conformational changes of AChE-tabun complex prior to an aging process in the AChE active site ([@b1]; [@b6]).

Tabun can produce centrally-mediated seizure activity, that rapidly progresses to status epilepticus and contributes to profound brain damage ([@b21]; [@b30]). The exposure of experimental animals to tabun in convulsions-inducing doses may result in irreversible lesions in the central nervous system (CNS) that can be manifested as behavioral effects in survivors that have convulsed ([@b9]). Therefore, the ability of antidotes to block the acute neurotoxic effects of tabun and prevent development of irreversible lesions in the CNS is important for successful antidotal treatment. Generally, the oximes exert more potent effects in the peripheral compared to central system due to their poor penetration into the CNS. Nevertheless, there are published results demonstrating the penetration of oximes into CNS and subsequent reactivation of nerve agent-inhibited AChE in the brain ([@b3]; [@b29]). Although the rate of the reactivation of nerve agent-inhibited AChE in the brain is lower compared to the peripheral system, the role of CNS is important for survival from nerve agent exposure ([@b21]; [@b11]).

As the ability of currently used monopyridinium (e.g. pralidoxime) and bispyridinium oximes (e.g. obidoxime) to counteract the neurotoxic effects of tabun is generally poor ([@b16]), the replacement of commonly used oximes with a more effective oxime has been a long-standing goal for the treatment of tabun poisoning ([@b5]). For this purpose, new bispyridinium oximes K117 \[1,5-bis(4-hydroxyiminomethylpyridinium)-3-oxapentane dibromide\] and K127 \[1-(4-hydroxyiminomethylpyridinium)-5-(4-carbamoylpyridinium)--3-oxapentane dibromide\] ([Fig. 1](#fig1){ref-type="fig"}) were synthesized ([@b18]; [@b24]) to improve the efficacy of antidotal treatment in eliminating tabun-induced neurotoxicity.

![Chemical structures of oximes studied.](utxm19-232-f1){#fig1}

The aim of this study was to compare the neuroprotective potency of newly developed oximes (K117, K127) with currently available oxime (obidoxime) in combination with an anticholinergic drug atropine in tabun-poisoned rats. The tabun-induced neurotoxic signs were determined using a functional observational battery, a non-invasive and relatively sensitive type of neurological examination for a wide range of neurobiological functions including measurements of sensory, motor, and autonomic nervous functions.

Materials and methods
=====================

Animals
-------

Male albino Wistar rats weighing 200--230 g were purchased from Konarovice (Czech Republic). They were kept in an air-conditioned room (22 ± 2°C and 50 ± 10% relative humidity, with lights from 7.00 to 19.00 h) and allowed access to standard food and tap water ad libitum. The rats were divided into groups of eight animals. Handling of the experimental animals was performed in compliance with relevant laws and institutional guidelines and done under the supervision of the Ethics Committee of the Faculty of Military Health Sciences in Hradec Kralove (Czech Republic).

Enzymes and chemicals
---------------------

Tabun was obtained from Military Technical Institute in Brno (Czech Republic) and was 96% pure as assayed by acidimetric titration. All oximes studied of 98.5% purity were synthesized at the Department of Toxicology of the Faculty of Military Health Sciences in Hradec Kralove (Czech Republic). Their purities were analyzed using HPLC. All other drugs and chemicals of analytical grade were obtained commercially and used without further purification. All substances were administered intramuscularly (i.m.) at a volume of 1 mL/kg body weight (b.w.).

In vivo experiments
-------------------

Tabun was administered at a sublethal dose (180 μg/kg b.w. 80% LD~50~). One minute following tabun challenge, the rats were treated with atropine (21 mg/kg b.w.) alone or in combination with obidoxime, K117 or K127 in equitoxic doses corresponding to 5% of their LD~50~ values ([@b17]). The neurotoxicity of tabun was monitored using the functional observational battery at 24 h following tabun poisoning. The evaluated markers of tabun-induced neurotoxicity in experimental animals were compared with the parameters obtained from control rats given saline instead of tabun and antidotes at the same volume.

The functional observational battery consists of 47 measurements of sensory, motor and autonomic nervous functions. Some of them are scored ([Table 1](#tbl1){ref-type="table"}), the others are measured in absolute units ([@b7]; [@b8]; [@b23]). The first evaluation was obtained when tabun-poisoned rats were in the home cage. The observer evaluated each animal\'s posture, palpebral closure, and involuntary motor movements. Then, each rat was removed from the home cage and briefly hand-held. The exploratory activity, piloerection, and other skin abnormalities were noted. Salivation and nose secretion were also registered and scored. Then, the rats were placed on a flat surface which served as an open field. A timer was started for 3 min during which the frequency of rearing responses was recorded. Rearing is the special kind of movement characterized by raising (both forelimbs are put up). This kind of movement is typical for exploratory behavior of rats. At the same time, gait characteristics were noted and ranked, and arousal, stereotypy, and bizarre behaviors and abnormal posture were evaluated. At the end of the third minute, the number of fecal boluses and urine pools on the adsorbent pad was registered. Reflex testing comprising recording each rat\'s response to the frontal approach of the blunt end of a pen, a touch of the pen to the posterior flank, and an auditory clic stimulus was also used. The response to a pinch on the tail and the ability of pupils to constrict in response to light were then assessed. These measures were followed by a test for the aerial righting reflex and by the measurements of forelimb and hindlimb grip strength, body weight, rectal temperature, and finally hindlimb landing foot splay. The whole battery of tests required approximately 6--8 min per rat. The observer of behavior did not know about the design of experiments. Motor activity data were collected shortly after finishing of the functional observational battery, using an apparatus for testing of a spontaneous motor activity of laboratory animals (constructed at the Faculty of Military Health Sciences, Hradec Kralove, Czech Republic). The animals were placed for a short period (10 min) in the measuring cage and their movements (total, horizontal, and vertical activity) were recorded.

###### 

Functional observational battery (FOB).

                        Scored values only                                                                                                                                                                                                                     
  --------------------- -------------------- ----------- ------------- ---------------------------------------- ----------------------------------------- ------------------------------- ------------------------ ---------------------- -------------------- -----------------------------------
  Posture                                                              sitting or standing                      rearing                                   asleep                          flattened                lying on side          crouched over        head bobbing
  Catch difficulty                                                     passive                                  normal                                    defense                         flight                   escape                 aggression           
  Ease of handling                                                     very easy                                easy                                      moderately difficult            difficult                                                            
  Muscular tonus        atonia               hypotonia   normal        hypertonia                               rigidity                                  fasciculations                                                                                       
  Lacrimation                                            none          slight                                   severe                                    crusta                          colored crusta                                                       
  Palpebral closure                                                    open                                     slightly drooping                         half-way drooping               completely shut          ptosis                                      
  Endo-exophthalmus                          endo        normal        exo                                                                                                                                                                                     
  Piloerection                                           no            yes                                                                                                                                                                                     
  Skin abnormalities                                     normal        pale                                     erythema                                  cyanosis                        pigmented                cold                   injury               
  Salivation                                             none          sllight                                  severe                                                                                                                                         
  Nose secretion                                         none          slight                                   severe                                    colored                                                                                              
  Clonic movements                                       normal        repetitive movements of mouth and jaws   nonrhythmic quivers                       mild tremors                    severe tremors           myoclonic jerks        clonic convulsions   
  Tonic movements                                        normal        contraction of extensors                 opisthotonus                              emprosthotonus                  explosive jumps          tonic convulsions                           
  Gait                                                   normal        ataxia                                   overcompensation of hindlimbs movements   feet point outwards from body   forelimbs are extended   walks on tiptoes       hunched body         body is flattened against surface
  Gait score                                                           normal                                   slightly impaired                         somewhat impaired               totally impaired                                                     
  Mobility score                                                       normal                                   slightly impaired                         somewhat impaired               totally impaired                                                     
  Activity                                                             very low                                 sporadic                                  reduced                         normal                   enhanced               permanent            
  Tension                                                none          partial (ears)                           stupor                                                                                                                                         
  Stereotypy                                             none          head weaving                             body weaving                              grooming                        circling                 others                                      
  Bizarre behavior                                       none          head                                     body                                      self-mutilation                 abnormal movements       others                                      
  Approach response                                                    no reaction                              normal                                    slow reaction                   energetic reaction       exaggerated reaction                        
  Touch response                                                       no reaction                              normal                                    slow reaction                   energetic reaction       exaggerated reaction                        
  Click response                                                       no reaction                              normal                                    slow reaction                   energetic reaction       exaggerated reaction                        
  Tail-pinch response                                                  no reaction                              normal                                    slow reaction                   energetic reaction       exaggerated reaction                        
  Pupil size                                 miosis      normal        mydriasis                                                                                                                                                                               
  Pupil response                                         no reaction   normal reaction                                                                                                                                                                         
  Righting reflex                                                      normal                                   slightly uncoordinated                    lands on side                   lands on back                                                        

Data analysis
-------------

Data collected with the functional observational battery and motor activity assessment include categorial, ordinal, and continuous values. Statistical analyses were performed on a PC with a special interactive program NTX ([@b7]). The categorial and ordinal values were formulated as contingency tables and judged consecutively by Chi-squared test of homogeneity, Concordance-Discordance test, and Kruskal-Wallis test, respectively. The continual data were assessed by successive statistical tests: CI for Delta, Barlett test for Equality of Variance, Williams test and Test for Distribution Functions ([@b28]). The differences were considered significant when *p* \< 0.05.

Results
=======

Six of eight tabun-poisoned rats survived till the end of experiment (24 h following the intoxication). When tabun-poisoned rats were treated with atropine alone, seven of eight tabun poisoned rats survived within 24 h after tabun challenge. On the other hand, all tabun-poisoned rats treated with atropine in combination with one of the tested oximes survived till the end of experiment.

The results of the experiments related to the measurement of tabun-induced neurotoxicity at 24 h following tabun poisoning are divided into three parts (activity and neuromuscular measures, sensorimotor and excitability measures, and autonomic measures---[@b23]) and summarized in [Tables 2](#tbl2){ref-type="table"}--[4](#tbl4){ref-type="table"}. The observation of neurotoxic signs indicated that many functional disorders in poisoned rats lasted at least 24 h not only in tabun-poisoned rats but also in tabun-poisoned rats treated with atropine alone or in combination with K117 and obidoxime. Tabun produced passive behavior of rats during handling and retention, miosis, and a decrease in muscule tone at 24 h following tabun administration. The exploratory and rearing activity were significantly decreased and gait was severely impaired. In addition, no reaction during recording each rat\'s response to an auditory clic stimulus was observed. Non-treated tabun-poisoned rats and tabun-poisoned rats treated with atropine alone or atropine combined with K117 were not able to constrict their pupils in response to light due to tabun-induced miosis. A marked decrease in limb grip strength, food receiving, body temperature, and spontaneous horizontal as well as vertical motor activity were also observed at 24 h following tabun challenge ([Tables 2](#tbl2){ref-type="table"}--[4](#tbl4){ref-type="table"}). On the other hand, K127 in combination with atropine was able to prevent some tabun-induced signs of neurotoxicity observed at 24 h following tabun challenge with the exception of passive behavior of rats during handling and retention, miosis, gait impairment, a decrease in food receiving, body temperature, and spontaneous horizontal as well as vertical motor activity ([Tables 2](#tbl2){ref-type="table"}--[4](#tbl4){ref-type="table"}).

###### 

The values of tabun-induced activity and neuromuscular neurotoxic markers measured at 24 h following tabun challenge by the functional observational battery (No 1--2, 4--14 scored values, No 3, 15--21 values in absolute units).

  24 hours   Controls (*n* = 8)                Tabun-A + K117 (*n* = 8)   Tabun-A + K127 (*n* = 8)   Tabun-A + obidoxime (*n* = 8)            Tabun-A (*n* = 7)   Tabun (*n* = 6)                                                                                                                                                                              
  ---------- --------------------------------- -------------------------- -------------------------- ---------------------------------------- ------------------- ---------------------------------------- ------- ----------------------------------------- ------- ---------------------------------------- ------- ---------------------------------------- -------
  1          posture                           1.00                                                  3.00[\*](#tf2-1){ref-type="table-fn"}                        3.00[\*](#tf2-1){ref-type="table-fn"}            3.00[\*](#tf2-1){ref-type="table-fn"}             3.00[\*](#tf2-1){ref-type="table-fn"}            3.00[\*](#tf2-1){ref-type="table-fn"}    
  2          muscular tonus                    0.00                                                  −2.00[\*](#tf2-1){ref-type="table-fn"}                       0.00                                             0.00                                              −2.00[\*](#tf2-1){ref-type="table-fn"}           −2.00[\*](#tf2-1){ref-type="table-fn"}   
  3          rearing                           8.25                       4.27                       0.63[\*](#tf2-1){ref-type="table-fn"}    1.77                5.00                                     5.71    1.63[\*](#tf2-1){ref-type="table-fn"}     0.92    0.75[\*](#tf2-1){ref-type="table-fn"}    1.75    2.25[\*](#tf2-1){ref-type="table-fn"}    3.11
  4          hyperkinesis                      0.00                                                  2.00[\*](#tf2-1){ref-type="table-fn"}                        0.00                                             5.00[\*](#tf2-1){ref-type="table-fn"}             0.00                                             0.00                                     
  5          tremors                           0.00                                                  2.00[\*](#tf2-1){ref-type="table-fn"}                        0.00                                             2.00[\*](#tf2-1){ref-type="table-fn"}             0.00                                             0.00                                     
  6          clonic movements                  0.00                                                  1.00[\*](#tf2-1){ref-type="table-fn"}                        0.00                                             1.00[\*](#tf2-1){ref-type="table-fn"}             0.00                                             0.00                                     
  7          tonic movements                   0.00                                                  3.00[\*](#tf2-1){ref-type="table-fn"}                        0.00                                             0.00                                              0.00                                             0.00                                     
  8          gait                              0.00                                                  7.00[\*](#tf2-1){ref-type="table-fn"}                        5.00[\*](#tf2-1){ref-type="table-fn"}            0.00                                              7.00[\*](#tf2-1){ref-type="table-fn"}            1.00[\*](#tf2-1){ref-type="table-fn"}    
  9          ataxia                            0.00                                                  2.00[\*](#tf2-1){ref-type="table-fn"}                        0.00                                             0.00                                              0.00                                             2.00[\*](#tf2-1){ref-type="table-fn"}    
  10         gait score                        0.00                                                  2.00[\*](#tf2-1){ref-type="table-fn"}                        0.00                                             0.00                                              0.00                                             0.00                                     
  11         mobility score                    1.00                                                  3.00[\*](#tf2-1){ref-type="table-fn"}                        1.00                                             1.00                                              1.00                                             1.00                                     
  12         activity                          4.00                                                  1.00[\*](#tf2-1){ref-type="table-fn"}                        4.00                                             1.00[\*](#tf2-1){ref-type="table-fn"}             2.00[\*](#tf2-1){ref-type="table-fn"}            1.00[\*](#tf2-1){ref-type="table-fn"}    
  13         RRF                               1.00                                                  1.00                                                         1.00                                             1.00                                              1.00                                             1.00                                     
  14         RRV                               1.00                                                  1.00                                                         1.00                                             1.00                                              1.00                                             1.00                                     
  15         landing foot splay (mm)           94.00                      12.47                      78.63[\*](#tf2-1){ref-type="table-fn"}   12.64               105.50                                   20.26   111.13[\*](#tf2-1){ref-type="table-fn"}   15.97   89.31                                    40.57   59.88                                    39.66
  16         forelimb grip strength (kg)       5.75                       0.82                       4.26[\*](#tf2-1){ref-type="table-fn"}    1.06                5.39                                     1.11    5.98                                      0.90    5.13                                     2.05    4.95                                     1.01
  17         hindlimb grip strength (kg)       1.14                       0.22                       0.49[\*](#tf2-1){ref-type="table-fn"}    0.20                1.06                                     0.16    1.06                                      0.23    0.81[\*](#tf2-1){ref-type="table-fn"}    0.31    0.67[\*](#tf2-1){ref-type="table-fn"}    0.10
  18         grip strength of all limbs (kg)   19.01                      1.41                       11.96[\*](#tf2-1){ref-type="table-fn"}   2.92                19.55                                    3.79    20.23                                     2.40    12.93[\*](#tf2-1){ref-type="table-fn"}   6.33    11.30[\*](#tf2-1){ref-type="table-fn"}   2.71
  19         vertical activity                 121.00                     112.29                     16.75[\*](#tf2-1){ref-type="table-fn"}   28.22               30.13[\*](#tf2-1){ref-type="table-fn"}   38.04   10.50[\*](#tf2-1){ref-type="table-fn"}    6.55    25.25[\*](#tf2-1){ref-type="table-fn"}   29.49   30.13[\*](#tf2-1){ref-type="table-fn"}   30.34
  20         horizontal activity               12.63                      17.82                      1.88                                     4.55                2.63                                     3.11    0.13                                      0.35    3.25                                     7.23    3.50                                     7.21
  21         total motor activity              133.63                     127.29                     18.63[\*](#tf2-1){ref-type="table-fn"}   32.46               32.75                                    40.70   10.63[\*](#tf2-1){ref-type="table-fn"}    6.67    28.50[\*](#tf2-1){ref-type="table-fn"}   35.94   33.63                                    36.33

*p* \< 0.05 (comparison with the control values).

###### 

The values of tabun-induced sensorimotor and excitability neurotoxic markers measured at 24 h following tabun challenge by the functional observational battery (scored values).

  24 hours   Controls (*n* = 8)    Tabun-A + K117 (*n* = 8)   Tabun-A + K127 (*n* = 8)   Tabun-A + obidoxime (*n* = 8)           Tabun-A (n = 7)   Tabun (*n*= 6)                                                                                                                                                           
  ---------- --------------------- -------------------------- -------------------------- --------------------------------------- ----------------- --------------------------------------- -- --------------------------------------- -- --------------------------------------- -- --------------------------------------- --
  1          catch difficulty      2.00                                                  1.00[\*](#tf3-1){ref-type="table-fn"}                     1.00[\*](#tf3-1){ref-type="table-fn"}      1.00[\*](#tf3-1){ref-type="table-fn"}      1.00[\*](#tf3-1){ref-type="table-fn"}      1.00[\*](#tf3-1){ref-type="table-fn"}   
  2          ease of handling      2.00                                                  1.00[\*](#tf3-1){ref-type="table-fn"}                     1.00[\*](#tf3-1){ref-type="table-fn"}      1.00[\*](#tf3-1){ref-type="table-fn"}      1.00[\*](#tf3-1){ref-type="table-fn"}      1.00[\*](#tf3-1){ref-type="table-fn"}   
  3          arousal (GSC)         1.00                                                  4.00[\*](#tf3-1){ref-type="table-fn"}                     2.00[\*](#tf3-1){ref-type="table-fn"}      1.00                                       4.00                                       2.00[\*](#tf3-1){ref-type="table-fn"}   
  4          tension               0.00                                                  0.00                                                      0.00                                       0.00                                       0.00                                       0.00                                    
  5          vocalization          0.00                                                  0.00                                                      0.00                                       0.00                                       0.00                                       0.00                                    
  6          stereotypy            0.00                                                  0.00                                                      0.00                                       0.00                                       0.00                                       0.00                                    
  7          bizarre behavior      0.00                                                  0.00                                                      0.00                                       0.00                                       0.00                                       0.00                                    
  8          approach response     2.00                                                  2.00                                                      2.00                                       2.00                                       2.00                                       1.00                                    
  9          touch response        2.00                                                  2.00                                                      2.00                                       2.00                                       2.00                                       1.00[\*](#tf3-1){ref-type="table-fn"}   
  10         click response        2.00                                                  3.00[\*](#tf3-1){ref-type="table-fn"}                     2.00                                       3.00[\*](#tf3-1){ref-type="table-fn"}      2.00                                       3.00[\*](#tf3-1){ref-type="table-fn"}   
  11         tail-pinch response   2.00                                                  2.00                                                      2.00                                       2.00                                       2.00                                       2.00                                    

*p* \< 0.05 (comparison with the control values).

###### 

The values of tabun-induced autonomic neurotoxic markers measured at 24 h following tabun challenge by the functional observational battery (Nos 1--7, 10--11, 15 scored values, Nos 8--9, 12--14 values in absolute units).

  24 hours   Controls (*n* = 8)      Tabun-A + K117 (*n* = 8)   Tabun-A + K127 (*n* = 8)   Tabun-A + obidoxime (*n* = 8)             Tabun-A (*n* = 7)   Tabun (*n* = 6)                                                                                                                                                                              
  ---------- ----------------------- -------------------------- -------------------------- ----------------------------------------- ------------------- ---------------------------------------- ------- ----------------------------------------- ------- ---------------------------------------- ------- ---------------------------------------- -------
  1          lacrimation             0.00                                                  0.00                                                          0.00                                             0.00                                              0.00                                             4.00[\*](#tf4-1){ref-type="table-fn"}    
  2          palpebral closure       1.00                                                  1.00                                                          1.00                                             1.00                                              1.00                                             1.00                                     
  3          endo/exophtalmus        0.00                                                  0.00                                                          0.00                                             0.00                                              0.00                                             0.00                                     
  4          fur abnormalities       0.00                                                  0.00                                                          0.00                                             0.00                                              0.00                                             0.00                                     
  5          skin abnormalities      0.00                                                  0.00                                                          0.00                                             0.00                                              0.00                                             0.00                                     
  6          salivation              0.00                                                  0.00                                                          0.00                                             0.00                                              0.00                                             0.00                                     
  7          nose secretion          0.00                                                  3.00[\*](#tf4-1){ref-type="table-fn"}                         0.00                                             0.00                                              0.00                                             3.00[\*](#tf4-1){ref-type="table-fn"}    
  8          urination               1.25                       1.58                       2.25                                      4.46                0.75                                     1.49    2.88                                      3.60    1.00                                     1.29    1.17                                     2.40
  9          defecation              0.00                                                  0.00                                                          0.00                                             0.00                                              0.00                                             0.00                                     
  10         pupil size              0.00                                                  −2.00[\*](#tf4-1){ref-type="table-fn"}                        −2.00[\*](#tf4-1){ref-type="table-fn"}           −1.00[\*](#tf4-1){ref-type="table-fn"}            −2.00[\*](#tf4-1){ref-type="table-fn"}           −2.00[\*](#tf4-1){ref-type="table-fn"}   
  11         pupil response          1.00                                                  0.50[\*](#tf4-1){ref-type="table-fn"}                         1.00                                             1.00                                              0.50[\*](#tf4-1){ref-type="table-fn"}            0.00[\*](#tf4-1){ref-type="table-fn"}    
  12         food receiving (%)      100.00                     0.00                       20.50[\*](#tf4-1){ref-type="table-fn"}    1.60                22.50[\*](#tf4-1){ref-type="table-fn"}   2.67    34.00[\*](#tf4-1){ref-type="table-fn"}    4.28    26.13[\*](#tf4-1){ref-type="table-fn"}   10.84   37.50[\*](#tf4-1){ref-type="table-fn"}   23.15
  13         body weight (g)         243.38                     16.80                      282.88[\*](#tf4-1){ref-type="table-fn"}   12.63               272.88                                   18.09   287.25[\*](#tf4-1){ref-type="table-fn"}   14.00   223.86                                   19.55   227.50                                   12.29
  14         body temperature (°C)   37.08                      0.09                       36.20[\*](#tf4-1){ref-type="table-fn"}    0.56                36.47[\*](#tf4-1){ref-type="table-fn"}   0.56    36.73[\*](#tf4-1){ref-type="table-fn"}    0.35    36.54[\*](#tf4-1){ref-type="table-fn"}   0.58    36.70[\*](#tf4-1){ref-type="table-fn"}   0.45
  15         respiration             0.00                                                  0.00                                                          0.00                                             0.00                                              0.00                                             0.00                                     

*p* \< 0.05 (comparison with the control values).

Discussion
==========

The potency of atropine alone to decrease tabun-induced acute neurotoxic signs is very low and corresponds to previously published results demonstrating that atropine alone is not able to prevent tabun-induced seizures and subsequent neurotoxic effects including brain damage following an exposure to tabun at sublethal and lethal doses ([@b13]; [@b22]; [@b15]). Therefore, anticholinergic drugs such as atropine need to be combined with an AChE reactivator for more effective antidotal treatment of tabun poisonings. To combine atropine with an oxime, the efficacy of antidotal treatment of tabun poisonings is increased, although the central reactivating efficacy of oximes is lower compared to peripheral reactivating efficacy ([@b11]). Pralidoxime, a currently available oxime for the treatment of poisonings with highly toxic organophosphates ([@b4]), seems to be practically ineffective in preventing tabun-induced neurotoxicity ([@b14]). Another commonly used oxime (obidoxime) is able to partly eliminate tabun-induced acute neurotoxicity following i.m. administration of tabun at a lethal dose, nevertheless, its neuroprotective efficacy is not satisfactory ([@b14]; [@b12]). The oxime HI-6 was demonstrated to be significantly less efficacious to block tabun-induced acute neurotoxicity than obidoxime ([@b14]; [@b12]). The unsatisfactory efficacy of the above mentioned oximes to prevent tabun-induced acute neurotoxicity can be explained due to low potency of these oximes in reactivating tabun-inhibited AChE in vitro and in vivo ([@b27]; [@b10]; [@b31]).

Our results demonstrate that the newly developed oxime K117 is completely ineffective to reduce tabun-induced acute neurotoxic signs and symptoms while the neuroprotective efficacy of another newly developed oxime K127 is markedly higher. The difference between neuroprotective efficacy of both newly developed oximes corresponds to the difference between their reactivating and therapeutic efficacy ([@b17]). The low neuroprotective, reactivating, and therapeutic efficacy of K117 can be caused by low dosage due to its high acute toxicity ([@b17]). The different toxicity of both newly developed oximes is probably caused by the differences in their chemical structure. The oxime K127 differs from K117 by the presence of carbamoyl group that diminishes its toxicity. On the other hand, the oxime K117 has two oxime groups that are responsible for its higher toxicity in comparison with K127.

The reason for a relatively high efficacy of K127 to reduce tabun-induced acute neurotoxic signs and symptoms is probably a chemical structure of its molecule because the potency of oximes to counteract the acute toxicity of nerve agents depends upon their chemical structure. The main structural features which influence their efficacy are the oxime functional group (its position and amount), the connecting linker for bisquaternary reactivators and other substituent(s) on the second heteroaromatic ring ([@b2]; [@b19]; [@b25]). For tabun poisonings, at least one oxime in position four on the heteroaromatic ring is necessary for substantial reactivating, therapeutic, and neuroprotective potency, whilst an oxime in position two has a low or no capability to counteract acute toxicity of tabun ([@b19]). Additionally, the optimal linker length suitable for tabun intoxication varies from three to four carbon--carbon bonds ([@b2]). The neuroprotective efficacy of the oxime K127 is slightly better compared to obidoxime, although its therapeutic and reactivating efficacy does not prevail the effects of obidoxime ([@b17]). Additionally, the difference of neuroprotective efficacy between K127 and obidoxime is not sufficient to replace currently used oximes by K127 for the treatment of acute tabun poisonings.
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